SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 113 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $14,000 | 0.0% | 25,009 | 0.0% | 0.00% | – |
Q1 2016 | $14,000 | +40.0% | 25,009 | +121.4% | 0.00% | – |
Q4 2015 | $10,000 | +11.1% | 11,298 | 0.0% | 0.00% | – |
Q3 2015 | $9,000 | -78.0% | 11,298 | -32.6% | 0.00% | – |
Q1 2015 | $41,000 | 0.0% | 16,763 | +3.1% | 0.00% | – |
Q4 2014 | $41,000 | -70.5% | 16,260 | -23.7% | 0.00% | – |
Q2 2014 | $139,000 | -10.3% | 21,301 | -8.8% | 0.00% | – |
Q1 2014 | $155,000 | +84.5% | 23,350 | +32.5% | 0.00% | – |
Q4 2013 | $84,000 | +10.5% | 17,624 | +15.5% | 0.00% | – |
Q3 2013 | $76,000 | -6.2% | 15,254 | -1.2% | 0.00% | – |
Q2 2013 | $81,000 | – | 15,443 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |